Choi YW - Search Results

1

A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system.

Yi SW, Yune TY, Kim TW, Chung H, Choi YW, Kwon IC, Lee EB, Jeong SY. Yi SW, et al. Among authors: choi yw. Pharm Res. 2000 Mar;17(3):314-20. doi: 10.1023/a:1007553106681. Pharm Res. 2000. PMID: 10801220

2

Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial chemoembolization.

Yi SW, Kim YH, Kwon IC, Chung JW, Park JH, Choi YW, Jeong SY. Yi SW, et al. Among authors: choi yw. J Control Release. 1998 Jan 2;50(1-3):135-43. doi: 10.1016/s0168-3659(97)00127-2. J Control Release. 1998. PMID: 9685880

3

Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.

Choi Y, Lim S, Yoon HY, Kim BS, Kwon IC, Kim K. Choi Y, et al. Expert Opin Drug Deliv. 2019 Aug;16(8):835-846. doi: 10.1080/17425247.2019.1648426. Epub 2019 Jul 30. Expert Opin Drug Deliv. 2019. PMID: 31343904 Review.

4

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment.

Park J, Choi Y, Chang H, Um W, Ryu JH, Kwon IC. Park J, et al. Theranostics. 2019 Oct 17;9(26):8073-8090. doi: 10.7150/thno.37198. eCollection 2019. Theranostics. 2019. PMID: 31754382 Free PMC article. Review.

5

Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound.

Choi Y, Han H, Jeon S, Yoon HY, Kim H, Kwon IC, Kim K. Choi Y, et al. Pharmaceutics. 2020 Oct 15;12(10):974. doi: 10.3390/pharmaceutics12100974. Pharmaceutics. 2020. PMID: 33076520 Free PMC article.

6

Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafish.

Chang H, Yhee JY, Jang GH, You DG, Ryu JH, Choi Y, Na JH, Park JH, Lee KH, Choi K, Kim K, Kwon IC. Chang H, et al. J Control Release. 2016 Dec 28;244(Pt B):205-213. doi: 10.1016/j.jconrel.2016.07.025. Epub 2016 Jul 17. J Control Release. 2016. PMID: 27435681

7

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death.

Choi Y, Yoon HY, Kim J, Yang S, Lee J, Choi JW, Moon Y, Kim J, Lim S, Shim MK, Jeon S, Kwon IC, Kim K. Choi Y, et al. Pharmaceutics. 2020 Nov 29;12(12):1165. doi: 10.3390/pharmaceutics12121165. Pharmaceutics. 2020. PMID: 33260446 Free PMC article.

8

In vitro skin penetration and pharmacodynamic evaluation of prostaglandin E1 ethyl ester, a vasoactive prodrug of prostaglandin E1, formulated into alcoholic hydrogels.

Park HS, Yang SW, Choi SU, Choi HG, Yong CS, Choi YW, Lee J. Park HS, et al. Among authors: choi yw, choi hg, choi su. Pharmazie. 2006 Nov;61(11):933-7. Pharmazie. 2006. PMID: 17152986

9

Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity.

Shim MK, Yang S, Park J, Yoon JS, Kim J, Moon Y, Shim N, Jo M, Choi Y, Kim K. Shim MK, et al. J Nanobiotechnology. 2022 Oct 4;20(1):436. doi: 10.1186/s12951-022-01644-x. J Nanobiotechnology. 2022. PMID: 36195911 Free PMC article.

10

Thoracic manifestations of Behçet syndrome: radiographic and CT findings in nine patients.

Ahn JM, Im JG, Ryoo JW, Kim SJ, Do YS, Choi YW, Oh YW, Yeon KM, Han MC. Ahn JM, et al. Among authors: choi yw. Radiology. 1995 Jan;194(1):199-203. doi: 10.1148/radiology.194.1.7997553. Radiology. 1995. PMID: 7997553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

738 results

Search Page

Filters